1). Balblanc JC, Conrozier T, Mathieu P, Tron AM, Bro-quet P, Piperno M, Richard M, Vignon E. Serum phospholipase A2 activity in osteoarthritis. Rev Rhum Ed Fr. 61:311–7. 1994.
2). Burns PD, Graf GA, Hayes SH, Silvia WJ. Effect of oxytocin on expression of cytosolic phospholipase A2 mRNA and protein in ovine endometrial tissue in vivo. Domestic animal endocrinology. 19:237–46. 2000.
3). Channon JY, Leslie CC. A calcium-dependent mechanism for associating a soluble arachidonoyl-hydrolyzing phospholipase A2 with membrane in the macrophage cell line RAW 264.7. J. Biol. Chem. 265:5409–13. 1990.
4). Clark JD, Lin LL, Kriz RW, Ramesha CS, Sultzman LA, Lin AY, Milona N, Knopf JL. A novel arachi -donic acid-selective cytosolic PLA2 contains a Ca2 +-dependnet translocation domain with homology to PKC and GAP. Cell. 65:1043–51. 1991.
5). Eyre D, Benya P, Buckwalter J, Frymoyer JW, Gordon SL. Intervertebral disc: Part B. Basic science perspective. New Perspectives in Low Back Pain. Park Ridge, IL: American Academy of Orthopaedic Surgeons;p. 147–207. 1989.
6). Franson RC, Saal JS, Saal JA. Human disc phospholipase A2 is inflammatory. Spine. 17:S129–132. 1992.
7). J⊘nsson B, Str⊘mqvist B. The clinical appearance of contained and non-contained lumbar disc herniation. lumbar disc herniation: a computeraided analysis of 2504 operations. J⊘nsson B, editor. ed.Lumbar Nerve Root Compression Syndromes. Sweden: Univeristy of Lund, Lund, Sweden;1995.
8). Kortekangas P, Aro HT, Nevalainen TJ. Group II phospholipase A2 in synovial fluid and serum in acute arthritis. Scand J Rheumatol. 23:68–72. 1994.
9). Kramer RM, Checani GC, Deykin A, Pritzker CR, Deykin D. Solubilization and properties of Ca2+-de pen -dent human platelet phospholipase A2. Biochem. Biophys. Acta. 878:394–403. 1986.
10). Kramer RM, Roberts EF, Manetta J, Putnam JE. The Ca2 +-sensitive cytosolic phospholipase A2 is a 100-kDa protein in human monoblast U937 cells. J. Biol. Chem. 266:5268–72. 1991.
11). Marshall LA, Bauer J, Sung ML, Chang JY. Evaluation of antirheumatic drugs for their effect in vitro on purified synovial fluid phospholipase A2. J Rheumatol. 18:59–65. 1991.
12). Mats G, Johanna V, Seppo R, Ilkka K, Heikki V, Seppo S, Ralph FR, Richard DG. A controlled biochemical and immunohistochemical study of human syn -ovil-type(group II) phospholipase A2 and inflammatory cells in macroscopically normal, degenerated, and herniated human lumbar disc tissues. Spine. 21(22):2531–8. 1996.
13). Muriel P, Pierre M, Pascal R, Pierre M, Anne MT, Gilles P, Marie JP, Michel R, Eric V. Phospholipase A2 activity in herniated lumbar discs: clinical correlations and inhibition by piroxicam. Spine. 22:2061–5. 1997.
14). Nevalainen TJ, Märki F, Kortesuo PT, Grütter MG, Di Macro S, Schmitz A. Synovial type (group II) phospholipase A2 in cartilage. J Rheumatol. 20:325–30. 1993.
15). Nygaard⊘ P, Mellgren SI, ⊘sterud B. The inflammatory properties of contained and noncontained lumbar disc herniation. Spine. 22:2484–8. 1997.
Article
16). Saal JS, Franson RC, Dobrow R, Saal JA, White AH, Goldthwaite N. High levels of inflammatory phospholipase A 2 activity in lumbar disc herniations. Spine. 15(7):674–8. 1990.
17). Sprangfort EV. The lumbar disc herniation: a computeraided analysis of 2504 operations. Acta Orthop Scand Suppl. 142:44–65. 1972.
18). Vignon E, Mathieu P, Louisot P, Vilamitjana J, Harmand MF, Richard M. Phospholipase A2 activity in human osteoarthritic cartilage. J Rheumatol Suppl. 18:35–8. 1989.
19). Yoshihara Y and Watanabe Y: Translocation of phospholipase A2 from cytosol to membranes in rat brain induced by calcium ions. Biochem. Biophys. Res. Comm. 170:484–90. 1990.